ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 303 filers reported holding ALKERMES PLC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,778,506 | -10.6% | 170,600 | -0.1% | 0.44% | -10.8% |
Q2 2023 | $5,346,353 | +11.1% | 170,810 | +0.1% | 0.49% | +19.2% |
Q1 2023 | $4,812,033 | +8.7% | 170,700 | +0.8% | 0.41% | +10.2% |
Q4 2022 | $4,426,422 | +2.0% | 169,400 | -12.8% | 0.37% | -4.6% |
Q3 2022 | $4,339,000 | -26.9% | 194,300 | -2.5% | 0.39% | -17.6% |
Q2 2022 | $5,937,000 | +55.2% | 199,300 | +37.1% | 0.48% | +92.7% |
Q1 2022 | $3,825,000 | +11.7% | 145,400 | -1.2% | 0.25% | +7.9% |
Q4 2021 | $3,423,000 | -24.6% | 147,200 | 0.0% | 0.23% | -34.6% |
Q3 2021 | $4,540,000 | +617.2% | 147,200 | +470.5% | 0.35% | +600.0% |
Q2 2021 | $633,000 | – | 25,800 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |